- Price is above Fair Value, showing premium demand versus the model.
SHARDACROP
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Sharda Cropchem Limited · Basic Materials · Agricultural Inputs
Latest close
814.0 INR
0.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -16.7% below the Trend Line and sits at 11.4% of its 52-week range. The latest completed week returned 0.4%, after a -10.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal.
Setup score
21
out of 100
Latest Close
814.0 INR
7 Aug 2026
1W Return
0.4%
latest completed week
4W Return
-10.0%
short-term follow-through
12W Return
-16.0%
quarterly tape
Trend Breadth
51.9%
27 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 44.12% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.4%
Latest completed week; four-week move -10.0%.
Indicator stack
29/25
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 44.12%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
56/100
26 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -16.7% below the Trend Line and sits at 11.4% of its 52-week range. The latest completed week returned 0.4%, after a -10.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.40
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -10.0% over four weeks, -16.0% over 12 weeks, and -17.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year27
Trend breadth51.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.22Latest activity-pressure read.
Pressure change-33.9%Four-week change in activity pressure.
Leadership-11.79Latest relative-leadership reading.
RS change-631.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength90/100Blend of value, momentum, and quality. Underlying universe rank 11; rank 1 is best.
Value94/100Relative valuation strength. Underlying universe rank 7; rank 1 is best.
Quality77/100Profitability and accounting quality. Underlying universe rank 24; rank 1 is best.
Momentum26/100Medium-term price momentum. Underlying universe rank 75; rank 1 is best.
Growth92/100Revenue and earnings growth. Underlying universe rank 9; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework99/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 9.1x Price divided by trailing earnings.
- Price / sales
- 1.2x Market value relative to trailing revenue.
- EV / EBITDA
- 5.3x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 2.2% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 34.3% Gross profit retained from each unit of revenue.
- Operating margin
- 17.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 2.6% Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 22.0% Latest one-year revenue growth.
- EPS growth
- 123.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -24.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.8% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 1.8% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment56/100
Weighted news tone is neutral across 26 relevant articles.
7 positive · 18 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-37.2%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+19.2%Week of 10 Apr.
Worst week-13.7%Week of 15 May.
Latest week+0.4%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses9
Sharp losses7
Recent vol4.5%13-week weekly-return volatility.
Base vol7.1%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank99 / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Agricultural Inputs
4-week rank43 / 47
Group average0.9%
Trend breadth19.1%
Trend19.1%active weekly trend signals
MD36.2%positive activity pressure
RS14.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 4/12.
Activity pressure 0.08; No reversal markers Next-Week ExpectancyNegative 44.12%Next-week expectancy is negative with a 44.12% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors73/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 55; Small Cap Core rank 8 SVQF99/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 24.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment56/100Weighted news tone is neutral across 26 relevant articles.
Maruti Suzuki, ABB India, Chennai Petro, Alkem Labs, Grasim, Sharda Cropchem Dividends: Last Day To Buy Shares To Qualify Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 814.0 INR | 0.4% | 977.5 INR | 670.9 INR | -1.22 | -11.79 | 1.2M | Off |
| 31 Jul 2026 | 810.8 INR | -6.1% | 976.8 INR | 668.3 INR | -1.10 | -11.80 | 1.6M | Off |
| 24 Jul 2026 | 863.4 INR | -2.9% | 978.1 INR | 665.8 INR | -0.99 | -4.19 | 546.4K | Off |
| 17 Jul 2026 | 889.3 INR | -1.7% | 977.8 INR | 663.1 INR | -0.94 | -3.96 | 609.4K | Off |
| 10 Jul 2026 | 904.7 INR | 0.5% | 977.5 INR | 660.6 INR | -0.91 | -1.61 | 899.7K | Off |
| 3 Jul 2026 | 900.7 INR | 2.8% | 977.7 INR | 658.2 INR | -0.99 | -2.07 | 323.8K | Off |
| 26 Jun 2026 | 876.5 INR | -2.7% | 976.5 INR | 655.8 INR | -1.11 | -3.78 | 0 | Off |
| 19 Jun 2026 | 900.8 INR | -2.4% | 975.9 INR | 653.6 INR | -1.11 | -0.64 | 165.6K | Off |
| 12 Jun 2026 | 923.3 INR | 3.4% | 972.3 INR | 651.1 INR | -1.10 | 3.86 | 392.4K | Off |
| 5 Jun 2026 | 892.7 INR | -1.4% | 967.2 INR | 648.6 INR | -0.93 | 1.86 | 201.2K | Off |
| 29 May 2026 | 905.0 INR | 1.3% | 963.2 INR | 646.4 INR | -0.65 | 2.86 | 1.4M | Off |
| 22 May 2026 | 893.1 INR | -7.8% | 961.7 INR | 643.6 INR | -0.43 | 1.24 | 2.4M | On |
| 15 May 2026 | 969.0 INR | -13.7% | 961.4 INR | 640.8 INR | -0.19 | 10.88 | 10.3M | On |
| 8 May 2026 | 1,122 INR | 4.6% | 955.8 INR | 637.7 INR | -0.10 | 26.64 | 1.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.